Osteopontin (OPN) plays a pivotal role in various immune responses and in¯ammatory diseases. OPN is expressed in various granulomatous diseases; however, the cellular and molecular role of OPN in these diseases is not well known. We analyzed the role of OPN in a b-glucan-induced hepatic granuloma model. First, we found that neither OPN de®ciency nor overexpression of OPN affected the number and the size of hepatic granulomas at day 7, indicating that OPN is not involved in the formation of hepatic granulomas at the early stages. Importantly, OPN did not in¯uence the liver tissue damage as de®ned by alanine aminotransferase and aspartate aminotransferase levels at early stages. Second, OPN de®ciency resulted in the reduction of IL-12 and IFN-g production at early stages. Third, at late stages, OPN de®ciency resulted in a decrease in the number and size of hepatic granulomas, and a reduction of liver tissue injury. This was due to the reduction of the cellular recruitment including macrophages, CD4 T cells and dendritic cells into the liver, and the reduction of tumor necrosis factor (TNF)-a production in the liver. In contrast, overexpression of OPN resulted in the persistence of granuloma formation. These data suggest that OPN affects the persistence of hepatic granuloma formation. Our results indicate that OPN up-regulates the production of IL-12 and IFN-g within the granulomas at early stages, and OPN has an additional role in the regulation of cellular recruitment and TNF-a production at late stages that determine the severity of liver tissue injury.
Introduction
Granulomas are localized in¯ammatory reactions, which are often elicited against persistent antigenic irritants that are not easily cleared by phagocytic cells. They can be a part of both immune protection and disease pathology during the course of various infectious and autoimmune diseases (1) . Recent studies showed that granulomas contained not only macrophages and T cells, but also functionally mature dendritic cells (DC) which possess potent antigen-presenting function and can activate T cells (2±5). When T cell-dependent antigens enter the circulation and are captured by Kupffer cells, the traf®c of DC precursors in the liver is accelerated. DC precursors capture antigen and mature in the liver, then migrate to the T cell area of the hepatic lymph nodes (LN). Here, they stimulate activation and expansion of naive CD4 T cells. Finally, activated CD4 T cells migrate back to the liver through the circulation and participate in the formation of granulomas (2, 3, 6) . These observations indicate that granuloma formation is an ongoing immune response.
b-glucan is a component of the cell wall fraction of yeast and is a T cell-independent antigen. It has been used to induce hepatic granulomas upon i.v. injection. It was shown that Kupffer cells play a critical role in b-glucan-induced granuloma formation by producing chemokines such as CCL2/MCP-1 which recruit in¯ammatory cells into the liver (7) . Indeed, in CCL2-de®cient mice, pulmonary granuloma formation in response to Schistosoma mansoni eggs was blunted (8) and in CCR2-de®cient mice, which lack a prominent receptor for CCL2, hepatic granuloma formation induced by b-glucan was signi®cantly decreased (9) .
Osteopontin (OPN) is an extracellular matrix protein containing an Arg±Gly±Asp (RGD) sequence. The protein has diverse functions including mediating cell adhesion and migration by interacting with CD44 and integrins such as a v b 3 (10±14). OPN is also known as early T lymphocyte activation gene-1 (Eta-1) because its expression is found in T cells early in the course of activation (15) . Recently, it was suggested that OPN was a key cytokine, contributing to the development of T h 1-type immunity and co-stimulation of human T cell activation (16±21). Importantly, OPN expression has been found in various granulomatous diseases such as tuberculosis and sarcoidosis (20, 22±25) . While an important role for OPN in granuloma formation is indicated by the observed impairment of granuloma formation induced by polyvinyl pyrolidone in OPN-de®cient (OPN ±/± ) mice (16) , the cellular and molecular role of OPN during the course of liver injury and hepatic granuloma formation remains poorly de®ned. Therefore, we investigated the role of OPN in hepatic granulomatous disease using the b-glucan-induced hepatic granuloma model. We demonstrate in this study that OPN is signi®cantly induced within the hepatic granulomas after bglucan treatment and affects the persistence of hepatic granuloma formation through two distinct mechanisms. First, OPN up-regulates the production of IL-12 and IFN-g within the granulomas at early stages. Second, at late stages, OPN has additional roles in the regulation of cellular recruitment and upregulation of tumor necrosis factor (TNF)-a production, which results in the liver tissue damage.
Methods

Mice
Speci®c pathogen-free male C57BL/6 mice (7±8 weeks old) were obtained from SLC Japan. C57BL/6 Q 129 OPN ±/± mice previously generated (26) were backcrossed to C57BL/6 in our animal facility for 10 generations. OPN-transgenic (OPNTg) mice were generated as described previously (27) and were backcrossed to C57BL/6 for >15 generations. The genotype of all mice was con®rmed by PCR analysis as described previously (26, 27) . All animals were housed individually in a speci®c pathogen-free facility with unlimited access to water and laboratory chow. The experiment was approved by the Animal Care Committee of our institute and was conducted in accordance with the guidelines of the institutional animal care policy.
Induction of liver granulomas and assessment of liver damage
Mice were injected via the tail vein with 1 mg/mouse of yeast b-glucan (Zymosan A; Sigma, St Louis, MO) suspended in 200 ml PBS. At the indicated times, mice were killed and liver specimens were sampled. Granuloma formation was con®rmed with hematoxylin & eosin staining of formalin-®xed 5-mm thick liver sections. The number and the size of granulomas in the section were analyzed by using NIH Image software. The degree of liver ®brosis was histologically evaluated. Brie¯y, liver sections were stained with Azan to visualize collagen ®ber. The percentage of ®brosis area per section was analyzed using NIH Image software. Alternatively, hepatocellular damage was determined by serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels.
Real-time quantitative PCR for OPN and chemokine gene expression in the liver
Total RNA was isolated from liver using TRIzol Reagent (Life Technologies) and reverse transcribed into cDNA by using ReverTra Ace (Toyobo, Japan). The expression of OPN, inducible nitric monoxide synthase (iNOS), CCL4/MIP-1b, CCL2/MCP-1, CCL5/RANTES, CCL3/MIP-1a and CXCL9/ monokine induced by IFN-g (Mig) was determined by PCR using LightCycler±FastStart DNA Master SYBR Green 1 systems (Roche Diagnostics). The sense primer for OPN was 5¢-ACGACCATGATTGGCAGTG-3¢ and the anti-sense primer was 5¢-TTACCTCAGTCCATAAGCAA-3¢. The sense primer for iNOS was 5¢-CTTCTCAGCCACCTT-3¢ and the antisense primer was 5¢-CCTCACATACTGTGGACG-3¢. The sense primer for CCL4 was 5¢-CTCTCTCTCCTCTTGCTCGT-3¢ and the antisense primer was 5¢-CTCCAAGTCACTCATGT-ACTC-3¢. The sense primer for CCL2 was 5¢-CCCCAAGAA-GGAATGGGTCC-3¢ and the antisense primer was 5¢-GGTT-GTGGAAAAGGTAGTGG-3¢. The sense primer for CCL5 was 5¢-CCGCCAAGTGTGTGCCAACCC-3¢ and the antisense primer was 5¢-GGGGATTACTGGAGTGGCATCC-3¢. The sense primer for CCL3 was 5¢-TCCACCACTGCCCTT GC-3¢ and the antisense primer was 5¢-GTGATGTATTCTTGGACCC-3¢. The sense primer for CXCL9 was 5¢-TCCTTTTGGGCATCATCTTC-3¢ and the antisense primer was 5¢-TGAACGACGACGACTTT-GG-3¢. The sense primer for b-actin was 5¢-TGGAATCCT-GTGGCATCCATGAAAC-3¢ and the anti-sense primer was 5¢-TAAAACGCAGCTCAGTAACAGTCCG-3¢. The reaction mixture containing a cDNA sample was prepared according to the manufacturer's protocols.
OPN and cytokine measurement
Whole liver was homogenized in PBS. The homogenates were centrifuged, and then the levels of OPN, IFN-g, IL-12, TNF-a, IL-10 and IL-4 in supernatants were measured by ELISA. Hepatic LN cells (2.5 Q 10 5 /well per 200 ml) were incubated in 96-well plates for 48 h with anti-mouse CD3 antibody (5 mg/ml, 145-2C11; PharMingen). The levels of IL-2 and IFN-g in each culture supernatant were measured by ELISA (BD PharMingen for IFN-g, TNF-a, IL-10, IL-4 and IL-2.; IBL, Fujioka, Japan for OPN; and Biosource for IL-12). The detection limits of the assay for OPN, IFN-g, IL-12, TNF-a, IL-10, IL-4 and IL-2 were 1 ng/ml, 31.3 pg/ml, 7.8 pg/ml, 15.6 pg/ ml, 31.3 pg/ml, 7.3 pg/ml and 3.1 pg/ml respectively.
Immunohistochemistry
Wild-type C57BL/6 mice and OPN ±/± mice, injected with bglucan, were sacri®ced at indicated days, and liver was obtained. Liver was embedded in Tissue-Tek OCT compound (Sakura Finetechnical, Tokyo, Japan), frozen in liquid nitrogen and cut by a cryostat into 5-mm thick sections. The following anti-mouse antibodies were used: biotin-labeled MCP-1 (4E2/ MCP; BD PharMingen), F4/80 (A3-1; Caltag), DEC-205 (NLDC-145; BMA Biomedicals), biotin-labeled CD4 (H129.19; BD PharMingen) and anti-mouse OPN Rabbit IgG (O-17; IBL Fujioka, Japan). After inhibition of endogenous peroxidase activity (and endogenous biotin activity for biotinconjugated primary antibodies using Blocking Kit SP-2001; Vector), the sections were incubated with primary antibodies at 4°C overnight. They were treated with horseradish peroxidase-conjugated goat anti-rat IgG in the case of F4/80 and DEC-205, horseradish peroxidase-conjugated goat antirabbit IgG in the case of OPN (Jackson ImmunoResearch) or peroxidase-conjugated streptavidin; in the case of MCP-1 and CD4 (Nichirei). After visualization with 3,3¢-diamino-benzidine (Nichirei), slides were counterstained with methyl green. 
Flow cytometric immuno¯uorescence analysis
Data analysis
Statistical signi®cance of difference was evaluated by two-way ANOVA or multiple comparison methods by Fisher. P values <0.05 were considered signi®cant.
Results
Augmentation of OPN expression in b-glucan-treated livers
Since strong expression of OPN has been reported in a variety of granulomatous diseases such as sarcoidosis and tuberculosis in humans (20,22±24), we ®rst investigated whether OPN was expressed in the liver after injection of b-glucan. In livers from untreated mice, a low level of OPN mRNA expression was detected. However, after b-glucan challenge, the level increased signi®cantly, peaking at day 7 and then gradually decreased, returning to normal levels at day 28 (Fig. 1A) . To con®rm the production of OPN protein in the liver, ELISA and immunohistochemical staining were performed. The production of OPN protein in the liver reached a peak at 14 days after b-glucan challenge and OPN was strongly expressed within the granulomas (Fig. 1B and C) .
Persistence of hepatic granuloma formation is reduced in OPN ±/± mice To con®rm that OPN is critically involved in the process of bglucan-induced liver granuloma formation, OPN ±/± mice and wild-type mice were challenged with b-glucan. The number of granulomas in wild-type mice increased dramatically, peaking at day 14, then signi®cantly decreased at day 21 and returned to the almost normal levels at day 28. The kinetics of this granuloma formation is similar to OPN expression shown in Fig. 1 . We found that the number of granulomas was signi®cantly decreased in OPN ±/± mice at day 14 ( Fig. 2A , c and d and B: wild-type mice 1540 T 88/cm 2 , OPN ±/± mice 1123 T 99/cm 2 , mean T SEM, P = 0.0293). Unlike previous report (16) , we found that the number of granulomas was not different between wild-type mice and OPN ±/± mice at day 7 ( Fig. 2A, a  and b and B) . Furthermore, we analyzed the size and the area of granulomas per section. We found that the size of the granulomas in OPN ±/± mice was signi®cantly smaller than that of wild-type mice at day 14 ( Fig. 2A, c and d and C, P < 0.001). Similarly, the area of granulomas in OPN ±/± mice at day 14 was signi®cantly smaller than that in wild-type mice ( Fig. 2C , P = 0.002). Notably, the size and the area of granulomas were not signi®cantly different between the two groups at day 7 ( Fig. 2A , a and b and C). High magni®cation microphotography showed that there was no signi®cant difference in histology between the two groups at day 14; granulomas consisted mainly of epithelial cells and mononuclear leukocytes in both groups ( Fig. 2A, e and f) . These results indicate that OPN is involved in the persistence of hepatic granuloma formation.
Absence of OPN dose not alter hepatic chemokine expression induced by b-glucan injection It has been also demonstrated that chemokines and chemokine receptors play a critical role in the recruitment of in¯ammatory cells and the formation of granulomas (8, 9, 28, 29) . Thus, we investigated whether the reduction of granuloma persistence in OPN ±/± mice was explained by down-regulation of chemokine expression in the liver. Although the mRNA expression of CCL4, CCL2, CCL5, CXCL9 and CCL3 in the liver was markedly induced after bglucan challenge, there was no signi®cant difference between wild-type mice and OPN ±/± mice at all time points tested. Interestingly, we found that the mRNA expression level of CCL4 and CCL2 was increased, peaking at day 7, and was decreased at day 14; in contrast, the mRNA expression levels of CCL5, CXCL9 and CCL3 remained elevated at day 14 (Fig. 3A) . Next we checked protein expression of a key chemokine, CCL2, in the liver at day 14 by immunohistochemistry. Unlike OPN expression, which was expressed within the granulomas (Fig. 1C) , CCL2 protein was strongly expressed in hepatocytes in both groups (Fig. 3B) . Our data suggest that the reduction of the granuloma persistence in OPN ±/± mice is not explained by the reduction of chemokine production.
The recruitment of in¯ammatory cells into the liver is decreased in OPN ±/± mice
It has been demonstrated that granuloma formation involves not only macrophages and lymphocytes, but also mature DC (2±5). In addition, OPN has been shown to be a chemotactic factor for T cells and macrophages (10, 20, 30) . Recently, it was demonstrated that OPN was involved in the migration of DC to the draining lymph nodes from the skin (31) . Therefore, we hypothesized that the reduction of the granuloma persistence in OPN ±/± mice was related to the reduction of the cellular recruitment. Thus, we examined the cellular components of the granulomas at day 14 by immunohistochemistry. In wildtype mice, macrophages, de®ned by F4/80 expression (Fig. 4A, a) , were distributed throughout the granulomas and in hepatic sinusoids, and CD4 + T cells were also found in the granulomas and sinusoids (Fig. 4A, b) . In contrast, DEC-205 + DC were only found within the granulomas (Fig. 4A, c) . In OPN ±/± mice, the distribution pattern of macrophages, CD4 T cells and DC was very similar to that detected in wild-type mice (Fig. 4A, d±f) . However, the number of those cells in the liver was signi®cantly decreased in OPN ±/± mice, accompanying the reduction of granuloma size and at day 14 ( Fig. 4A and  B) . These data indicate that OPN, which is expressed within the granulomas after b-glucan treatment, can induce the migration of not only macrophages and CD4 T cells, but also DC into the granulomatous sites and the reduction of the granuloma persistence in OPN ±/± mice is due to the reduction of cellular recruitment into the liver at day 14.
Absence of OPN dose not alter regional LN reactions
We investigated whether the immune response is induced in hepatic LN in this hepatic granuloma model induced by bglucan. We found that hepatic LN were signi®cantly enlarged, and the number of DC, CD4 T cells and CD8 T cells in hepatic LN at day 14 increased~5-to 7-fold as compared to untreated hepatic LN in wild-type mice (Fig. 5A ). These data indicate that an immune response is induced in the hepatic LN in the bglucan-induced hepatic granuloma model. Next, we investigated whether the reduction of the granuloma persistence in OPN ±/± mice was due to an alteration of the immune response in the hepatic LN. However, there was no signi®cant difference in total cell number of hepatic LN between wild-type mice and OPN ±/± mice at day 14 ( Fig. 5A : wild-type mice 28.1 Q 10 5 , OPN ±/± mice 28.9 Q 10 5 ). The number of CD4 T cells, CD8 T cells and DC as de®ned by CD11c and class II MHC doublepositive cells in the hepatic LN was not different between the two groups (Fig. 5A) . We further analyzed IL-2 and IFN-g production by hepatic LN cells at day 14. Hepatic LN cells were stimulated with anti-CD3 for 48 h in vitro, and were tested for IL-2 and IFN-g production. Neither IL-2 nor IFN-g levels differed between wild-type mice and OPN ±/± mice (Fig. 5B) . These data suggest that the reduction of the granuloma persistence in OPN ±/± mice is not due to the alteration of the immune response in the regional hepatic LN.
OPN affects the cytokine production in the liver and subsequent liver injury
As it was demonstrated that OPN was a key cytokine contributing to the development of a T h 1-type immune OPN affects the persistence of granuloma formation 481 Downloaded from https://academic.oup.com/intimm/article-abstract/16/3/477/656715 by guest on 13 December 2018 response (16, 17, 19) , we next analyzed cytokine production in the liver in OPN ±/± mice after b-glucan treatment. After bglucan challenge, both wild-type mice and OPN ±/± mice showed increased production of IFN-g in the liver as compared to untreated mice. However, OPN ±/± mice showed lower levels of IFN-g at day 7 as compared to wild-type mice (Fig. 6A) . We also found that IL-12 production in the liver at day 7 was reduced in OPN ±/± mice (Fig. 6A) . The production of IL-4 and IL-10 in the liver was also augmented after b-glucan challenge in both wild-type mice and OPN ±/± mice; however, there was no signi®cant difference between the two groups (Fig. 6B) . TNF-a has been shown to be involved in the process of hepatocellular damage (28, 32) . Therefore, the production of TNF-a in the liver was analyzed. After b-glucan challenge, the level of TNF-a in the liver was signi®cantly increased in mice of both genotypes at day 7, but there was no difference between the two groups. At day 14, on the other hand, while TNF-a levels continued to rise in wild-type mice, OPN ±/± mice showed a signi®cant decrease in the levels of this cytokine (Fig. 6C , P = 0.0256). Importantly, this difference in the levels of liver TNF-a was re¯ected in alterations in the serum ALT (Fig. 6C , P = 0.0017) and AST levels ( Fig. 6C , P = 0.0122) in OPN ±/± mice. The overexpression of exogenous OPN in lymphoid tissues induces persistence of granuloma formation and subsequent ®brotic change in the liver To con®rm that OPN is a critical molecule in the granuloma formation, we used OPN-Tg mice in which exogenous OPN is overexpressed in lymphoid tissues under the control of the E m promoter (27) . After b-glucan challenge, the number of granulomas at day 7 was not different between wild-type mice and OPN-Tg mice (Fig. 7A) . We found that the number of granulomas was signi®cantly increased in OPN-Tg mice at day 14, but not in wild-type mice (Fig. 7A: OPN-Tg mice 2166 T 94/cm 2 , wild-type mice 1540 T 88/cm 2 , mean T SEM, P = 0.0004). In addition, the number of granulomas returned to almost basal levels in wild-type mice at day 21, but we could still detect signi®cant number of granulomas in OPN-Tg mice at day 21 ( Fig. 7A : OPN-Tg mice 503 T 102/cm 2 , wild-type mice 127 T 16/cm 2 , mean T SEM, P = 0.0492). Next we measured iNOS mRNA expression as an indicator of in¯am-matory responses. The mRNA expression of iNOS in wild-type mice peaked at day 7, then gradually declined and returned to the basal levels at day 21. In OPN-Tg mice, in contrast, highlevel expression of iNOS was maintained through day Fig. 7B ). This persistence of hepatic granulomas in OPNTg mice was accompanied by elevated levels of serum ALT and AST (Fig. 7C) . Interestingly, we found that the subsequent ®brotic changes in the liver were more severe in OPN-Tg mice at day 28 (Fig. 7D) . These data indicate that OPN may be a key factor for controlling the persistence of granuloma formation and in¯ammatory responses, and thus the severity of liver tissue injury.
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Discussion
OPN has been clearly characterized as a chemotactic factor for smooth muscle cells, endothelial cells, ®broblasts, lymphocytes and macrophages by interacting with integrin and CD44 (10±14,33,34) . OPN is expressed in various types of cells including activated T cells and macrophages (15, 22) . It was recently shown that OPN protein was strongly expressed in the pathological foci of patients with various granulomatous diseases including tuberculosis and sarcoidosis (20, 22, 24) . The role of OPN in granulomatous diseases is thought to involve regulation of the migration of in¯ammatory cells from the circulation into the in¯ammatory sites (20, 30) . In fact, pulmonary granuloma formation induced by embolization of Schistosoma mansoni eggs was delayed and the granulomas formed contained fewer macrophages in OPN ±/± mice in comparison to wild-type mice (25) . Furthermore, it was reported that OPN ±/± mice were defective in granuloma formation in skin following s.c. injection of polyvinyl pyrolidone (16) . More importantly, the degree of OPN protein expression in granulomas of tuberculosis correlated with the prognosis of patients (24) . These data suggest that OPN is involved not only in the pathological process of granuloma formation, but also in the immunological reaction against pathogens. Thus, it is very important to de®ne the cellular and molecular role of OPN during the course of granuloma formation.
Here, using the hepatic granuloma model induced by bglucan, we found that the expression of OPN protein in the liver was signi®cantly induced from day 7 to 21 after injection in wild-type mice. Furthermore, immunohistochemical analysis demonstrated that OPN protein was present at high levels within the granulomas. These results suggest that OPN is involved in this hepatic granuloma formation induced by bglucan.
The ®rst important ®nding is that the absence of OPN does not affect the number and size of hepatic granulomas induced by b-glucan at early stages (at day 7). It should be noted that overexpression of OPN in OPN-Tg mice does not affect the number of granulomas at day 7. On the other hand, we found that the persistence of granuloma formation was reduced in OPN ±/± mice; the number and the size of granulomas were signi®cantly decreased in OPN ±/± mice at late stages (at day 14). Again, in sharp contrast, the number of granulomas was increased in OPN-Tg mice at late stages. Thus, OPN is involved in the persistence of granuloma formation. It has been shown that chemokines are critically involved in the process of granuloma formation (8, 9, 28, 29) . We found that the mRNA expression of CCL3, CCL4, CCL2, CCL5 and CXCL9 was signi®cantly induced after b-glucan treatment both in wildtype mice and OPN ±/± mice, but there was no difference between the two groups. Furthermore, we found that one of a key chemokine, CCL2 protein, was expressed in hepatocytes at day 14 in both wild-type and OPN ±/± mice. Thus, the reduction of the persistence of the granuloma formation in OPN ±/± mice was not explained by the reduction of chemokine expression.
In addition, we found that OPN de®ciency resulted in a reduced accumulation of macrophages, CD4 T cells and DC in the liver at day 14, but not at day 7. Recent investigations showed that OPN was involved in the migration of Langerhans Representative data from three independent experiments. n = 3. Data were expressed as a mean T SEM. *P < 0.05. **P < 0.005. NS, not signi®cant. cells/DC from the skin to the draining LN (31) . We demonstrated in this study that OPN can induce the migration of not only macrophages and CD4 T cells, but also DC to the granulomatous sites. Thus, the reduction of cellular recruitment into the liver in OPN ±/± mice accounts for the reduction of the persistence of granuloma formation at day 14. However, the critical question that should be raised here is why OPN de®ciency results only in the reduced recruitment of in¯am-matory cells at day 14, but not at day 7. It is likely that chemokines other than OPN are responsible for the initial stage of hepatic granuloma formation. In this regard, we demonstrated that the mRNA expression of chemokines is signi®cantly induced in the liver at day 7 after b-glucan treatment.
The second important ®nding in this paper is that the production of the T h 1-type cytokine, IFN-g, is signi®cantly decreased in the liver in OPN ±/± mice at day 7. Furthermore, IL-12 production in the liver was signi®cantly reduced in OPN ±/± mice at day 7, suggesting that OPN modulates the cytokine expression within the granulomas toward higher amounts of IFN-g production by up-regulating the IL-12 expression from macrophages. Importantly, the production of T h 2-type cyto- were measured by ELISA. Representative data from three independent experiments. n = 6. Serum ALT and AST levels in wild-type mice (open square) and OPN ±/± mice (closed square) after b-glucan treatment (untreated, day 7, 14, 21 and 28). n = 6. Data were expressed as mean T SEM. *P < 0.05. **P < 0.005. kines, IL-4 and IL-10, was not different between the two groups. Therefore, OPN may not be a regulator of classical T h 1/T h 2 paradigm (16, 17, 21) in this model. It has been reported that IFN-g mediates the pathogenesis of liver injury by regulating macrophage in®ltration and activation. IFN-g also stimulates TNF-a production from macrophages (35±37). In accordance with those reports, we found that TNF-a production in the liver was decreased in OPN ±/± mice at day Wild-type mice n = 9, OPN-Tg mice n = 11. Results are expressed as mean T SEM. *P < 0.05. **P < 0.005. NS, not signi®cant. 14 and that this lower TNF-a level was accompanied by reduced liver damage, as re¯ected by serum levels of ALT and AST in OPN ±/± mice at day 14.
Accumulating evidence indicates that T cell-dependent antigen-loaded DC migrate from the liver into the T cell area of the regional hepatic LN via hepatic lymph, where the DC present antigen and activate naive CD4 T cells. These activated T cells are then recruited back to the liver (2,6,38,39). Then we investigated whether cellular traf®cking and cytokine expression in regional hepatic LN differ between wild-type mice and OPN ±/± mice after b-glucan injection. Unexpectedly, although after b-glucan challenge the number of DC, CD4 T cells and CD8 T cells in the hepatic LN increased signi®cantly in both wild-type mice and OPN ±/± mice at day 14, there was no signi®cant difference between the two groups. Similarly, IL-2 and IFN-g production by hepatic LN cells after bglucan injection were not different between the two groups. This may be due to the nature of stimuli that we used in this experiment: b-glucan is a T cell-independent antigen, whereas in previous reports a T cell-dependent antigen was used (6) .
Based on these observations, we summarize the role of OPN in the b-glucan-induced liver granulomatous in¯amma-tion model in Fig. 8 . We have demonstrated in this study that in this hepatic granuloma model, OPN within granulomas induced by b-glucan treatment regulates the persistence of hepatic granuloma formation and liver tissue injury through two distinct mechanisms. First, at early stages of hepatic granuloma formation, OPN up-regulates the production of IL-12 and IFN-g within the granulomas. Second, at late stages of hepatic granuloma formation, OPN has an additional role in the regulation of cellular recruitment into the liver or into the granulomas and up-regulation of TNF-a production that determines the severity of liver tissue injury. However, in late stages of hepatic granuloma formation, OPN has an additional role in the regulation of cellular recruitment including macrophages, CD4 T cells and DC into the liver or into the granulomas, and up-regulation of TNF-a production. In this stage, the recruitment of in¯ammatory cells into the liver is also induced by chemokines.
Abbreviations
